GENEVA — In a comprehensive three-day strategic dialogue, representatives from Belgium and the World Health Organization (WHO) have met to review progress on their longstanding partnership and chart a forward-looking course for global public health. The high-level consultations concluded with a renewed commitment to bolster collaboration across critical areas, including universal health coverage (UHC), the fortification of fragile health systems, and the acceleration of equitable access to essential vaccines, medicines, and advanced health technologies.
The high-level Belgian delegation was led by H.E. Christophe Payot, Ambassador and Permanent Representative of Belgium to the United Nations and other international organizations in Geneva. Throughout the multi-day engagement, the delegation worked alongside WHO leadership and technical experts hailing from both WHO headquarters and the Regional Offices for Africa and for Europe. The discussions focused heavily on strategic alignment, examining how to smoothly harmonize WHO’s broader strategic directives with Belgium’s specific development cooperation priorities within an increasingly complex and evolving global health landscape.
During the dialogue, participants also exchanged vital updates regarding Belgium’s ongoing support for global health initiatives that were brought into sharp focus during the Belgian presidency of the Council of the European Union in 2024. This continuity of leadership and shared vision underscored the deep mutual trust underpinning the bilateral relationship.
Reflecting on the insights gained during the sessions, Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, emphasized the value of the partnership in navigating contemporary hurdles. "After listening to the leaders and experts of WHO we now better understand how they are navigating these challenging times," Mr. Van Acoleyen noted. "We are honoured that we can walk this road together."
Accelerating Equitable Access to Vaccines, Medicines and Health Technologies
A central pillar of the dialogue involved a rigorous review of the current status and major milestones achieved under the Access to Medicines programme, a critical global health initiative funded by Belgium. To ground the discussion in practical realities, the WHO illustrated its ongoing work and the distinct operational challenges it faces by presenting a detailed case study of country-level implementation in Senegal.
The presentation shed light on WHO’s overarching policies surrounding equitable access and the promotion of local manufacturing capacities for medical products. Both Belgian and WHO officials concurred on a shared strategic goal: ensuring the long-term financial and operational sustainability of the Access to Medicines initiative. Participants emphasized that sophisticated market-shaping strategies remain paramount to securing enduring success, preventing supply chain vulnerabilities, and making life-saving treatments permanently available to populations most in need.
Health Emergencies and Pandemic Prevention, Preparedness and Response
The dialogue naturally expanded into the pressing domain of health security, focusing extensively on the WHO’s central role in reinforcing the global architecture for health emergency prevention, preparedness, response, and resilience. Discussions centered on the ongoing international negotiations surrounding the pandemic agreement, as well as the practical application of the multidisciplinary "One Health" approach, which recognizes the interconnected health of humans, animals, and ecosystems.
To demonstrate the real-world impact of WHO’s field operations during acute crises, technical experts presented a sobering overview of critical health emergency response activities currently underway in Gaza. The debate also addressed looming systemic threats posed by the rapid acceleration of biological risks and zoonotic diseases, with particular attention dedicated to strengthening WHO’s engagement in proactive risk mitigation and early warning systems.
Universal Health Coverage (UHC)
Delving into the core engine of global health equity, participants evaluated the progress of the UHC-Partnership. They closely examined the tangible results achieved by the WHO with Belgian financial and technical backing over the 2021–2024 period, with a specific focus on outcomes in Belgium’s designated partner countries.

Looking ahead, the partners explored avenues for enhanced collaboration at the country level. This included discussions on achieving tighter operational alignment between WHO country office programmes and Belgium’s bilateral development cooperation frameworks. As a practical example, delegates reviewed the operational scope, successes, and ongoing hurdles faced on the ground in the Democratic Republic of Congo.
The visiting delegation also received a comprehensive recap of WHO’s strategic policies and ongoing programmatic work regarding mental health integration within the framework of primary health care. Beyond primary care and UHC, the two delegations evaluated progress across several other specialized areas of collaboration funded by Belgium, including targeted interventions against Neglected Tropical Diseases (NTDs) and the promotion of Sexual and Reproductive Health and Rights (SRHR). Both sides reaffirmed that an unyielding commitment to an evidence-based approach is indispensable for driving meaningful progress in these sensitive sectors.
The WHO expressed profound appreciation for Belgium’s steadfast commitment and multi-layered engagement, which was visibly demonstrated by the active participation of representatives from both the Belgian Federal government and the regional Flemish and Walloon governments.
"We thank you for your support, honesty, and strong engagement for global health," remarked Dr. Catharina Boehme, WHO Assistant Director-General for External Relations and Governing Bodies. "Your efforts in supporting our work in Mozambique and Senegal are clear examples of the crucial work we accomplish together."
Looking into the Future
As the strategic dialogue drew to a close, the partners turned their attention to the horizon, discussing the future architecture of the Belgium-WHO collaboration framework. This included mapping out the next steps for a multi-year agreement and tracking progress toward a renewed WHO-Belgium Country Cooperation Strategy.
Both parties acknowledged that this deepened partnership will play a vital role in supporting a robust global health agenda under the umbrella of the WHO’s 14th General Programme of Work (GPW14). There was a shared, unequivocal vision that Universal Health Coverage and health systems strengthening—serving as the foundational heartbeat of the GPW14 ambitions—will remain central priorities guiding WHO’s ongoing programmatic implementation.
Summarizing the overarching sentiment of the delegation, Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation at the Directorate-General Development Cooperation and Humanitarian Aid, affirmed the enduring value of the alliance.
"We recognize WHO as a trustworthy partner in global health," Mr. Brems stated. "We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels. It’s important we continue these discussions as we tread uncharted territories, and we look forward to working together for strong and sustained multilateralism."
